COMMUNIQUÉS West-GlobeNewswire

-
Revive Therapeutics Announces Cannabis Product Derivative Manufacturing and Development Facility
20/06/2019 -
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0475 Per Share
20/06/2019 -
Parallax Health Sciences Announces Initiative to Obtain a 510(K) Clearance for its Fotodigm® Enabled Remote Patient Monitoring Platform
20/06/2019 -
TeraRecon Receives First-of-Kind FDA Determination
20/06/2019 -
AgraFlora Organics Welcomes Collection of Industry Analysts, Institutional Investors and Media Personnel to June 25th Delta Greenhouse Tour; Broadcast To Be Made Available Online Via Corporate Website
20/06/2019 -
Innate Pharma to host key opinion leader call on IPH4102 “TELLOMAK” clinical trial design and rationale
20/06/2019 -
Innate Pharma organise une conférence téléphonique avec un expert sur le rationnel et le design de l’essai « TELLOMAK » d’IPH4102
20/06/2019 -
Addex Shareholders Approve All Resolutions at Annual General Meeting
20/06/2019 -
Genocea Announces Pricing of $36,750,000 Public Offering of Common Stock
20/06/2019 -
Atreca Announces Pricing of Initial Public Offering
20/06/2019 -
Cronos Group Inc. Announces Results of Vote for Election of Directors
20/06/2019 -
Scholar Rock Announces Pricing of Public Offering of Common Stock
20/06/2019 -
North Bud Farms Closes First Tranche of Private Placement Financing
19/06/2019 -
Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal
19/06/2019 -
Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common Stock
19/06/2019 -
DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
19/06/2019 -
Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors
19/06/2019 -
Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock
19/06/2019 -
Precision Optics Corporation, Inc. Announces the Passing of Dr. Kenneth Schwartz
19/06/2019
Pages